Upadacitinib in the treatment of difficult‐to‐treat psoriatic arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Upadacitinib in the treatment of difficult‐to‐treat psoriatic arthritis

Published:2024-06-17 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Graceffa D.¹^ORCID,Sperati F.²,Lora V.¹,Orsini D.¹,Spoletini G.³,Bonifati C.¹

Affiliation:

1. Department of Clinical Dermatology San Gallicano Dermatological Institute, IRCCS Rome Italy

2. UOSD Clinical Trial Center Biostatistics and Bioinformatics, IRCCS San Gallicano Dermatological Institute Rome Italy

3. General Surgery and Liver Transplantation Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20182

Reference7 articles.

1. Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort

2. Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis

3. Efficacy and safety of Upadacitinib in patients with psoriatic arthritis: 2‐year results from the phase 3 SELECT‐PsA 1 study;McInnes IB;Rheumatol Ther,2023

4. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial

5. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP